期刊文献+

结核分枝杆菌Rv3914抗原的克隆表达与纯化 被引量:1

Cloning,expression and purification of Rv3914 antigen of M.tuberculosis
原文传递
导出
摘要 目的构建结核分枝杆菌Rv3914蛋白的重组质粒,并在大肠埃希菌中表达及纯化,为结核病血清学诊断提供候选抗原。方法用PCR方法从结核分枝杆菌H37Rv基因组中扩增Rv3914基因片段,插入到pET-28b(+)载体中,构建pET28b-Rv3914重组质粒,转化大肠埃希菌E.coli BL21plysS(DE3),经IPTG诱导表达后,应用Ni-NTA亲和柱纯化重组蛋白。结果 PCR扩增出Rv3914基因序列,重组质粒经测序并经BLAST分析后发现无点突变。pET28b-Rv3914重组质粒在大肠埃希菌E.coli BL21plysS(DE3)中主要以可溶性形式表达,重组蛋白占细胞蛋白总表达量的30%以上,经Ni-NTA柱纯化后,得到纯度超过90%、相对分子质量约为14.7×103的目的蛋白质。结论高纯度结核分枝杆菌Rv3914重组蛋白的获得为研究结核互补特异性抗原组合在结核病血清诊断中的价值奠定了基础。 Objective To investigate the cloning and expression of Rv3914 antigen of M.tuberculosis,thus provide a candidate antigen for TB serodiagnosis.Methods The gene fragment encoding Rv3914 protein was amplified by PCR from the genome DNA of M.tuberculosis H37Rv strain and then inserted into corresponding site of the expression vector pET-28b(+).The recombinant plasmid pET28b-Rv3914 was transformed into E.coli BL21(DE3)pLysS strain and induced with IPTG.The recombinant protein was purified by Ni-NTA purification system.Results The inserted sequence of Rv3914 gene fragment was identical to the gene recorded in GeneBank.The expected molecular weight of 14.7 kDa recombinant protein was expressed in E.coli BL21 plysS(DE3) and amounted to more than 30% of total cell proteins.The recombinant protein was purified by Ni-NTA purification system with high purity(more than 90%).Conclusion The high purity of Rv3914 recombinant protein has potential applications for the specific serodiagnositic research of M.tuberculosis infection.
出处 《中国预防医学杂志》 CAS 2011年第11期902-905,共4页 Chinese Preventive Medicine
基金 "十一五"国家科技重大专项(2009ZX10004-313) "十一五"国家科技重大专项(2009ZX10003-017) 湖北省教育厅科研项目(B20101701)
关键词 结核分枝杆菌 Rv3914 克隆 表达 纯化 M.tuberculosis Rv3914 Clone Expression Purification
  • 相关文献

参考文献11

  • 1World Health Organization. Global tuberculosis control 2010 IMp. Geneva, Switzerland, WHO/HTM/TB/2010.07: 5-7.
  • 2Zhang SL, Zhao JW, Sun ZQ, et al. Development and evalua- tion of a novel multiple-antigen ELISA for serodiagnosis of tu- berculosis [J]. Tuberculosis, 2009, 89 (4): 278-284.
  • 3Cole ST, Brosch R, ParkhilI J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome se- quence [J]. Nature, 1998, 393 (6685): 537-544.
  • 4Sartain MJ, Slayden RA, Singh KK, et ag. Disease state differ entiation and identification of tuberculosis biomarkers via native antigen array profiling [J]. Mol Cell Proteomics, 2006, 5 (11): 2102-2113.
  • 5SarnbrookJ,RussellDW,黄培堂,译.分子克隆实验指南[M].3版.北京:科学出版社,2002:611-616.
  • 6刘忠华,兰国伟,吕冰,陈创夫,万康林.结核分枝杆菌分泌蛋白MPT64的克隆、表达、纯化和复性[J].中国预防医学杂志,2007,8(2):113-115. 被引量:4
  • 7Lin XH, Xu SF, Yang YP, etal. Purification and characteriza tion of anthranilate synthase component I (TrpE) from Myco bacterium tuberculosis H37Rv [J]. Protein Expr Purif, 2009 64 (1): 8-15.
  • 8Kunnath-Velayudhan S, Salamon H, Wang HY, etal. Perkins MD et al: Dynamic antibody responses to the Myeobaeterium tuberculosis proteome [J]. Proc Natl Acad Sci USA, 2010, 107 (33):14703- 14708.
  • 9Wallis RS, Pal M, Menzies D, et al. Biomarkers and diagnos- tics for tuberculosis: progress, needs, and translation into practice [J]. Lancet, 2010, 375 (9729): 1920-1937.
  • 10McNerney R, Daley P. Towards a point-of care test for active tuberculosis: obstacles and opportunities[J]. Nat Rev Micro- biol, 2011, 9 (3): 204-213.

二级参考文献5

  • 1Roche PW,Winter N,Triccas JA,et al.Expression of Mycobacterium tuberculosis MPT64 in recombinant mycosmegmatis:purification,immunogenicity and application to skin tests for tuberculosis.Clin Exp Immunol,1996,103:266-232.
  • 2Sambrook J,Fristsch EF,Maniatis T著.分子克隆实验指南.金冬雁,黎孟岚,张德政,等译.第2版.北京:科学出版社,1995.
  • 3Brian V G,Boris N.Design and optimization of a recombinant system for large-scale production of the MPT64 antigen from Mycobacterium tuberculosis.Protein Expression and Purification,2006,46:64-72
  • 4Mark J.S,Rlayden A.Disease state differentiation and identification of tuberculosis biomarkers via native antigen array profiling.Mol Cell Proto,2006,5:2102-2113.
  • 5吴雪琼,张俊仙,李洪敏,夏湘萱,刘军,金关甫.结核分枝杆菌MPT64蛋白的表达、纯化及初步应用[J].中国防痨杂志,2001,23(2):85-88. 被引量:13

共引文献3

同被引文献9

  • 1WHO. Global tuberculosis control.WHO report 2011[R].Geneva:World Health Organization,2011.
  • 2Zhang SL,Zhao JW,Sun ZQ. Development and evaluation of a novel multiple-antigen ELISA for serodiagnosis of tuberculosis[J].Tuberculosis(Edinb),2009,(04):278-284.
  • 3Jones GJ,Hewinson RG,Vordermeier HM. Screening of predicted secreted antigens from Mycobacterium bovis identifies potential novel differential diagnostic reagents[J].Clinical and Vaccine Immunology,2010,(09):1344-1348.
  • 4Cole ST,Brosch R,Parkhill J. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence[J].Nature,1998,(6685):537-544.
  • 5Zhang SL,Shen JG,Shen GH. Use of a novel multiplex probe array for rapid identification of Mycobacterium species from clinical isolates[J].World J Microbbiot Biot,2007,(12):1779-1788.
  • 6Zhao JW,Sun ZQ,Yang HG. Cloning,expression and immunological evaluation of a short fragment from Rv3391 of Mycobacterium tuberculosis[J].ANNALS OF MICROBIOLOGY,2011,(02):345-353.
  • 7Mahairas GG,Sabo PJ,Rickey M J. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M.bovis[J].Journal of Bacteriology,1996,(05):1274-1282.
  • 8Baassi L,Sadki K,Seghrouchni F. Evaluation of a multiantigen test based on B-cell epitope peptides for the serodiagnosis of pulmonary tuberculosis[J].International Journal of Tuberculosis and Lung Disease,2009,(07):848-854.
  • 9闫晓晓,王洪海,张舒林.RD区编码蛋白在结核病免疫诊断中的研究进展[J].现代生物医学进展,2010,10(20):3935-3940. 被引量:4

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部